CD4 and breast carcinoma: Compared with women who remained free of breast cancer, women diagnosed with breast cancer had decreases in the circulating percentage of total CD4+ helper T cells (−1.50% [95% CI, −2.56% to −0.44%]; P = .01) (Figure 1A).